Remission of Proteinuria in a Patient Affected by Crescentic IgA Nephropathy with Rapidly Progressive Glomerulonephritis Treated by Sodium-Glucose Cotransporter-2 Inhibitors: Casual or Causal Relationship?

• Main Authors: José C. De La Flor Merino (Author), Jacqueline Apaza Chávez (Author), Francisco Valga Amado (Author), Francisco Díaz Crespo (Author), Pablo Justo Avila (Author), Alexander Marschall (Author), Michael Cieza Terrones (Author), Patricia Núñez Ramos (Author), Elisa Ruiz Cicero (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Crescentic IgA nephropathy (IgAN) with rapidly progressive glomerulonephritis (RPGN) is often associated with rapidly declining kidney function. Up to this date, specific therapy for crescentic IgAN is still unknown. Accumulating evidence suggests that sodium-glucose co-transporter-2 inhibitors (SGL...